KIT and neoplasm: We performed WGS of 60 genomes from DNA isolated from tumor tissue and matched blood samples from 30 patients with GIST with pathogenic KIT mutations in exon 11 (Supplementary Fig. S1) to identify the genomic characteristics contributing to the development of KIT Δ557–558 in GISTs.